![Peter G. Ernster](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter G. Ernster
Director/Board Member at
The Philadelphia Orchestra Association
Profile
Peter G.
Ernster is the founder of Optio Research, Inc. He currently serves as Vice Chairman at The Philadelphia Orchestra Association.
Previously, he served as Chairman at Barrier Therapeutics, Inc. from 2003 to 2011, and as Senior Vice President-Business Management at Merck & Co., Inc. in 2000.
He also served as Chairman at Sopherion Therapeutics LLC and as an Advisory Board Member at Limulus Management Co. LLC.
Ernster holds a graduate degree from Rutgers State University of New Jersey and an undergraduate degree from New York University.
Peter G. Ernster active positions
| Companies | Position | Start |
|---|---|---|
The Philadelphia Orchestra Association
 The Philadelphia Orchestra Association Movies/EntertainmentConsumer Services Operates orchestra's | Director/Board Member | - |
Former positions of Peter G. Ernster
| Companies | Position | End |
|---|---|---|
Barrier Therapeutics, Inc.
 Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products in the field of dermatology | Chairman | 17/04/2011 |
| MERCK & CO., INC. | Corporate Officer/Principal | 30/11/2000 |
Optio Research, Inc.
 Optio Research, Inc. Miscellaneous Commercial ServicesCommercial Services Provides healthcare analysis and data services | Founder | - |
Limulus Management Co. LLC
 Limulus Management Co. LLC Investment ManagersFinance Limulus Management Co LLC invests in healthcare/life science companies located in the US. The firm focuses on companies with intellectual property positions and growth potential. It targets companies operating in the fields of biopharmaceutical technology and life sciences information. It provides financing for early stage capital requirements with an investment size ranging from $4 to $8 million. | Corporate Officer/Principal | - |
Sopherion Therapeutics LLC
 Sopherion Therapeutics LLC BiotechnologyHealth Technology Develops and commercializes anti-cancer therapies | Chairman | - |
Training of Peter G. Ernster
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
88
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Barrier Therapeutics, Inc.
Barrier Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products in the field of dermatology | Health Technology |
Sopherion Therapeutics LLC
Sopherion Therapeutics LLC BiotechnologyHealth Technology Develops and commercializes anti-cancer therapies | Health Technology |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Limulus Management Co. LLC
Limulus Management Co. LLC Investment ManagersFinance Limulus Management Co LLC invests in healthcare/life science companies located in the US. The firm focuses on companies with intellectual property positions and growth potential. It targets companies operating in the fields of biopharmaceutical technology and life sciences information. It provides financing for early stage capital requirements with an investment size ranging from $4 to $8 million. | Finance |
The Philadelphia Orchestra Association
The Philadelphia Orchestra Association Movies/EntertainmentConsumer Services Operates orchestra's | Consumer Services |
Optio Research, Inc.
Optio Research, Inc. Miscellaneous Commercial ServicesCommercial Services Provides healthcare analysis and data services | Commercial Services |
- Stock Market
- Insiders
- Peter G. Ernster
